Ulrike Leurs

527 total citations
20 papers, 318 citations indexed

About

Ulrike Leurs is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ulrike Leurs has authored 20 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ulrike Leurs's work include Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cancer-related gene regulation (4 papers). Ulrike Leurs is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cancer-related gene regulation (4 papers). Ulrike Leurs collaborates with scholars based in Denmark, Germany and Hungary. Ulrike Leurs's co-authors include Kasper D. Rand, Rasmus P. Clausen, Erika Orbán, Brian Lohse, Gábor Mező, Jesper L. Kristensen, Marilena Manea, Peter Öhlschläger, Andreas Marquardt and Philip A. Cole and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.

In The Last Decade

Ulrike Leurs

19 papers receiving 316 citations

Peers

Countries citing papers authored by Ulrike Leurs

Since Specialization

Citations

This map shows the geographic impact of Ulrike Leurs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Leurs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Leurs more than expected).

Fields of papers citing papers by Ulrike Leurs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Leurs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Leurs. The network helps show where Ulrike Leurs may publish in the future.

Co-authorship network of co-authors of Ulrike Leurs

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Leurs. A scholar is included among the top collaborators of Ulrike Leurs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Leurs. Ulrike Leurs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment 2025 ·Scientific Reports ·(unknown), Lisbeth Elster, Morten Lundh, (unknown), (unknown), (unknown), Ditte Marie Jensen, Ulrike Leurs, Jens Nielsen, Henrik H. Hansen, Kristian Agmund Haanes, Matilda Degn	0
2	Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect 2022 ·Scientific Reports ·(unknown), (unknown), Søren L. Pedersen, (unknown), Ulrike Leurs, Lise Rudkjær, Keld Fosgerau, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Lisbeth Elster	9
3	Exploring the NCS-382 Scaffold for CaMKIIα Modulation: Synthesis, Biochemical Pharmacology, and Biophysical Characterization of Ph-HTBA as a Novel High-Affinity Brain-Penetrant Stabilizer of the CaMKIIα Hub Domain 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ulrike Leurs, (unknown), (unknown), Sara M. Ø. Solbak, Petrine Wellendorph, Bente Frølund	7
4	Quantitative proteome comparison of human hearts with those of model organisms 2021 ·PLoS Biology ·Nora Linscheid, Alberto Santos, (unknown), Robert W. Mills, Kirstine Calløe, Ulrike Leurs, (unknown), Christian Stolte, Morten B. Thomsen, Bo Hjorth Bentzen, Pia R. Lundegaard, Morten S. Olesen, Lars Juhl Jensen, Jesper V. Olsen, Alicia Lundby	31
5	Silencing of spontaneous activity at α4β1/3δ GABA_A receptors in hippocampal granule cells reveals different ligand pharmacology 2020 ·British Journal of Pharmacology ·Nils Ole Dalby, (unknown), Ulrike Leurs, Petra Scholze, (unknown), Bente Frølund, Petrine Wellendorph	9
6	Improved prediction of HLA antigen presentation hotspots: Applications for immunogenicity risk assessment of therapeutic proteins 2020 ·Immunology ·(unknown), Carolina Barra, Birkir Reynisson, Heidi S. Schultz, Ulrike Leurs, Kasper Lamberth, Morten Nielsen	12
7	Quantitative proteomics characterization of acutely isolated primary adult rat cardiomyocytes and fibroblasts 2020 ·Journal of Molecular and Cellular Cardiology ·(unknown), (unknown), Navratan Bagwan, Ulrike Leurs, (unknown), (unknown), Morten Schak Nielsen, Bo Hjorth Bentzen, Jesper V. Olsen, Alicia Lundby	9
8	Mapping the Interactions of Selective Biochemical Probes of Antibody Conformation by Hydrogen–Deuterium Exchange Mass Spectrometry 2017 ·ChemBioChem ·Ulrike Leurs, Hermann Beck, Lea Bonnington, Ingo Lindner, (unknown), Kasper D. Rand	7
9	Synthesis and Characterisation of Substrate-Based Peptides as Inhibitors of Histone Demethylase KDM4C 2016 ·Protein and Peptide Letters ·(unknown), Ulrike Leurs, (unknown), (unknown), Kanchan Devkota, (unknown), (unknown), (unknown), Brian Lohse, Jesper L. Kristensen, Rasmus P. Clausen	2
10	The Impact of the ‘Austrian’ Mutation of the Amyloid Precursor Protein Transmembrane Helix is Communicated to the Hinge Region 2016 ·ChemistrySelect ·Walter Stelzer, Christina Scharnagl, Ulrike Leurs, Kasper D. Rand, Dieter Langosch	9
11	Charting the interactome of PDE3A in human cells using an IBMX based chemical proteomics approach 2015 ·Molecular BioSystems ·Eleonora Corradini, (unknown), Ulrike Leurs, Albert J. R. Heck, Nathaniel I. Martin, Arjen Scholten	7
12	Getting to the core of protein pharmaceuticals – Comprehensive structure analysis by mass spectrometry 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·Ulrike Leurs, (unknown), Kasper D. Rand	50
13	Substrate- and Cofactor-independent Inhibition of Histone Demethylase KDM4C 2014 ·ACS Chemical Biology ·Ulrike Leurs, Brian Lohse, Kasper D. Rand, (unknown), Erik Riise, Philip A. Cole, Jesper L. Kristensen, Rasmus P. Clausen	24
14	Dissecting the Binding Mode of Low Affinity Phage Display Peptide Ligands to Protein Targets by Hydrogen/Deuterium Exchange Coupled to Mass Spectrometry 2014 ·Analytical Chemistry ·Ulrike Leurs, Brian Lohse, (unknown), Philip A. Cole, Rasmus P. Clausen, Jesper L. Kristensen, Kasper D. Rand	17
15	Posttranslational Modifications of the Histone 3 Tail and Their Impact on the Activity of Histone Lysine Demethylases In Vitro 2013 ·PLoS ONE ·Brian Lohse, Charlotte Helgstrand, Jan B. L. Kristensen, Ulrike Leurs, Paul A. Cloos, Jesper L. Kristensen, Rasmus P. Clausen	18
16	GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate 2012 ·European Journal of Medicinal Chemistry ·Ulrike Leurs, Eszter Lajkó, Gábor Mező, Erika Orbán, Peter Öhlschläger, Andreas Marquardt, László Kőhidai, Marilena Manea	22
17	Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C) 2012 ·Bioorganic & Medicinal Chemistry Letters ·Ulrike Leurs, Rasmus P. Clausen, Jesper L. Kristensen, Brian Lohse	13
18	Design, synthesis, in vitro stability and cytostatic effect of multifunctional anticancer drug‐bioconjugates containing GnRH‐III as a targeting moiety 2011 ·Biopolymers ·Ulrike Leurs, Gábor Mező, Erika Orbán, Peter Öhlschläger, Andreas Marquardt, Marilena Manea	18
19	Enhanced Enzymatic Stability and Antitumor Activity of Daunorubicin-GnRH-III Bioconjugates Modified in Position 4 2011 ·Bioconjugate Chemistry ·Marilena Manea, Ulrike Leurs, Erika Orbán, Zsuzsa Baranyai, Peter Öhlschläger, Andreas Marquardt, (unknown), (unknown), (unknown), József Tóvári, Gábor Mező	28
20	Efficient synthesis of an (aminooxy) acetylated‐somatostatin derivative using (aminooxy)acetic acid as a ‘carbonyl capture’ reagent 2010 ·Journal of Peptide Science ·Gábor Mező, Ildikó Szabó, István Kertész, (unknown), Erika Orbán, Ulrike Leurs, Szilvia Bősze, Gábor Halmos, Marilena Manea	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact